Prompt & Proper Tick Removal Key to Preventing Lyme Disease

TickHow long does it take for a tick bite to cause infection? If I remove the tick within 24 hours, am I safe? What about 72 hours? What if I just found the tick but don’t know when it first attached? These questions and many more come up all the time, particularly here in California where tick and Lyme disease awareness are just beginning to grow.

Standard protocol has been to consider the risk quite low if the tick is removed within a 24-72 hour window. However, in this study by the California Lyme Disease Association and the Sonoma Mosquito and Vector Control District, the authors point out the importance of early and proper removal of any and all ticks. Bacterial transmission has occurred in as little as 6 hours.  

Common Allergy Medication May Be Effective In Starving and Killing the Bacteria That Causes Lyme Disease

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Common Allergy Medication May Be Effective In Starving and Killing the Bacteria That Causes Lyme Disease According to New Study

Study Offers Insights Into Metabolic Activity of Borrelia burgdorferi and May Lead to First Targeted Therapy for Lyme Disease

Portola Valley, CA — A new study funded by the Bay Area Lyme Foundation and conducted by Stanford School of Medicine researchers shows that loratadine, which is a common antihistamine frequently taken to treat allergy symptoms, may be able to help kill Borrelia burgdorferi, the bacteria associated with Lyme disease. Lyme disease is a potentially debilitating condition with 300,000 new cases in the US each year. The study was published in the Open Access publication Drug Design, Development and Therapy.

Bay Area Lyme Foundation Announces Scientific Advisory Board Appointments

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Bay Area Lyme Foundation Announces Scientific Advisory Board Appointments

National Organization Selects Key Researchers and Clinicians to Help Move Forward the Mission of Making Lyme Disease Easy to Diagnose and Simple to Cure

Portola Valley, CABay Area Lyme Foundation, the leading national nonprofit funder of innovative Lyme disease research, today announced the Bay Area Lyme Foundation Scientific Advisory Board members who will aid the organization in achieving the mission of making Lyme disease easy to diagnose and simple to cure. Consisting of some of the country’s leading Lyme researchers, the board was specifically developed to include researchers and clinicians from across the US who play a critical role in obtaining a better understanding of Lyme disease in the lab and in clinical practice. Lyme disease is the fastest-growing infectious disease in the US, a potentially debilitating condition that impacts 300,000 Americans each year.

Sasquatch Racing Trail Series Partners with Bay Area Lyme Foundation

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Sasquatch Racing Trail Series Partners with Bay Area Lyme Foundation

San Francisco, CA – Leading Bay Area trail racing series, Sasquatch Racing, is proud to announce the Bay Area Lyme (BAL) Foundation as a presenting sponsor for their 2015 racing season. The Bay Area Lyme Foundation is a national nonprofit organization dedicated to making Lyme disease easy to diagnose and simple to cure.

Interview with Emerging Leader Award Recipient Jerome Bouquet

Jerome Bouquet_20141030_162125_256“Lyme is a debilitating illness for which diagnosis is critical for cure.” –Dr. Jerome Bouquet

Jerome Bouquet, PhD, was recognized in May 2014 as an Emerging Leader in the field of Lyme research. This award recognizes creative ingenuity and novel approaches for the development of better diagnostics and treatment for Lyme disease. The award also carries a $100,000 project grant to fund a new research initiative. Here, Dr. Bouquet talks about his work in the field and his funded project, “Development of a Host Biomarker Assay for the Diagnosis of Acute and Post-Treatment Lyme Disease.”

Q: Earlier this year, you were recognized by Bay Area Lyme Foundation as one of the Emerging Leaders in the field of Lyme disease research.  Tell us about your project, what do you hope to accomplish?

A:The project emerged as a result of (1) the lack of sensitive diagnostics for Lyme disease; and (2) the expertise of our laboratory in next generation sequencing. We are developing the unbiased detection of a large number of pathogens. But Lyme disease is trickier, because Borrelia burgdorferi, the bacteria responsible for the disease, is only transiently present in the blood at low titer. So instead of looking for the pathogen, we are examining the human host at a cellular level. How do immune cells respond to the infection and how can we decode and measure their response? That’s what transcriptome profiling is.

2014: A Year in Review

It is that time of year when we reflect and take stock of all that’s happened over the past 12 months – the highs and the highlights and what it portends for the year ahead. As we quickly approach the close of 2014, we are proud of the progress that has been made and grateful to all those who helped create greater awareness, understanding, and discovery around Lyme disease, its agents, and its progression. It has been a year of collaboration and innovation across the research field with promising developments for new treatments and diagnostics

Bay Area Lyme Foundation Announces $1.2 Million in 2014 Grants Awarded

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Bay Area Lyme Foundation Announces $1.2 Million in 2014 Grants Awarded to Researchers throughout the United States

Portola Valley, CABay Area Lyme Foundation, the leading nonprofit funder of innovative Lyme disease research in the US, today announced the recipients of the 2014 grant cycle to fund research related to Lyme disease, which impacts 300,000 Americans each year. The organization awarded a total of $1.2 million to nine researchers across the US focused on making Lyme disease simple to diagnose and easy to cure.  Bay Area Lyme Foundation’s grant cycle runs throughout the year and involves researchers from most regions of the United States.  These researchers are working on projects to develop a better understanding of the disease and substantially improve its diagnosis and treatment.

Elet Hall, Ninja Warrior, Lyme Survivor

Elet Hall is nothing short of a marvel. This amazing athlete is a four-time competitor on American Ninja Warrior, where he is known as “The Natural” for his seemingly effortless runs. The first two years he successfully made it to the Las Vegas finals despite suffering from undiagnosed Lyme disease. Shortly after the 2013 finals, he woke up one day with facial paralysis and his joints and limbs numbed with fatigue. After being diagnosed and successfully treated for Lyme disease, he again returned in 2014 to triumph in his third attempt at the competition. After dominating Stage 1 and Stage 2 of the national finals, Elet finally succumbed to the floating doors in Stage 3, coming in 2nd place in his third attempt at the competition.

This year, Elet again returned to the ANW stage, with a dominating “run of the night” at the 2015 Pittsburgh Qualifiers. (Check out Elet’s facebook page for the video!and then headed to the Pittsburgh City Finals on August 10th. At the finals, Elet had a tough run, narrowly surviving a missed grab on the monkey bars before finally slipping on the last few doorknobs. Even with the surprising fall, however, Hall still was among the fastest finalists, qualifying him to move on to Las Vegas for the national finals and the battle for a $1 million grand prize. [Read here for more about the August finals.) Unfortunately it was not Elet’s year to walk away with the grand prize but we will be rooting for him in next year’s competition!!

Here in a November 2014 excerpt from a longer story on our Faces of Lyme feature, he shares some perspective about the challenges of fighting Lyme disease as an athlete:

Clinicians & Researchers Gather to Discuss Science of Lyme Disease

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Clinicians, Researchers Gather in Boston to Discuss Science of Lyme Disease — Conference Unites Lyme Disease Research Community

Boston, MA — A national scientific conference entitled “Lyme Borreliosis and Tick-Borne Illnesses: Diagnostics, Emerging Pathogens and Avenues for New Research,” brought a broad range of researchers and clinicians to Boston November 8 and 9 to discuss tick-borne diseases, share emerging ideas and knowledge, and assess the most promising avenues for research into the future. Held at Massachusetts General Hospital (MGH), the conference drew more than 200 people from across the country and around the world intent on collaborating through the power of science to find answers to some of the most complex and often-misunderstood diseases. The two-day forum, to which the Bay Area Lyme Foundation provided an unrestricted educational grant, also featured the presentation of awards recognizing several scientists for their contributions to the understanding and treatment of Lyme disease.

Interview with ELA Recipient Lisa Blum

Lisa Blum is an enterprising young scientist and postdoctoral fellow at Stanford University School of Medicine, working in the lab of Dr. Bill Robinson. Earlier this year she was recognized as a Bay Area Lyme Foundation Emerging Leader and received a $100,000 project grant. Here she talks about her research, life at Stanford, and the impact of the award.  

2014 Blum ELA picture Resized_156

Q: Earlier this year, your project, “Sequencing of Antibody Responses to Borrelia burgdorferi Infection — Generation of Recombinant Antibodies with Diagnostic and Therapeutic Utility” helped earn you recognition as a Bay Area Lyme Emerging Leader.  Tell us about your project and what you hope to accomplish.

Antibodies are proteins produced by the immune system that protect us from infections, but in some cases the antibodies themselves can damage the human body. Our goal is to characterize antibodies produced during different stages of Lyme disease, and to generate monoclonal antibodies that can be used to improve on existing Lyme disease treatments and diagnosis.